Literature DB >> 8288270

Immunologic and biochemical analysis of TNT-1 and TNT-2 monoclonal antibody binding to histones.

G K Miller1, G S Naeve, S A Gaffar, A L Epstein.   

Abstract

Two novel murine monoclonal antibodies that bind to intracellular antigens, designated TNT-1 and TNT-2, have been generated by immunizing mice with nuclear extracts from human lymphoma cells. The monoclonal antibodies were initially identified by indirect immunofluorescence on lymphoma cell lines and subsequently were found to stain the nucleus of all cell types from several species including plants by indirect immunofluorescence techniques. Immunoblot analysis demonstrated that TNT-1 bound to a protein of 22 kD and TNT-2 bound to two proteins of 15 and 22 kD, consistent with the known molecular weight of histones. To characterize their immunoreactivity, competition radioimmunoassays were performed using purified histone fractions H1, H2a, H2b and H3. By these assays, TNT-1 was found to bind to histone fraction H1 and TNT-2 to an epitope common to histone fractions H1 and H3. Histones are found in abundance in the nucleus of the cell and are known to play a major role in chromosome structure and gene expression. Upon cell death, histones remain tightly bound to DNA and consequently provide an abundant intracellular antigen that can be exploited in targeting necrotic cells, such as those found in tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8288270     DOI: 10.1089/hyb.1993.12.689

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  6 in total

Review 1.  An overview of translational (radio)pharmaceutical research related to certain oncological and non-oncological applications.

Authors:  Marlein Miranda Cona; Peter de Witte; Alfons Verbruggen; Yicheng Ni
Journal:  World J Methodol       Date:  2013-12-26

2.  Cytoreductive chemotherapy improves the biodistribution of antibodies directed against tumor necrosis in murine solid tumor models.

Authors:  Julie K Jang; Leslie A Khawli; Ryan Park; Brian W Wu; Zibo Li; David Canter; Peter S Conti; Alan L Epstein
Journal:  Mol Cancer Ther       Date:  2013-10-15       Impact factor: 6.261

3.  Immunocytokines: a review of molecules in clinical development for cancer therapy.

Authors:  Thomas List; Dario Neri
Journal:  Clin Pharmacol       Date:  2013-08-20

4.  Updated developments on molecular imaging and therapeutic strategies directed against necrosis.

Authors:  Dongjian Zhang; Meng Gao; Qiaomei Jin; Yicheng Ni; Jian Zhang
Journal:  Acta Pharm Sin B       Date:  2019-02-13       Impact factor: 11.413

5.  Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours.

Authors:  J K J Ahlskog; C Schliemann; J Mårlind; U Qureshi; A Ammar; R B Pedley; D Neri
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

6.  Chemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumors.

Authors:  Fares Al-Ejeh; Jocelyn M Darby; Michael P Brown
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.